Funder
Joint Funds for the innovation of science and Technology, Fujian province
discipline subject of school management, Fujian University of Traditional Chinese Medicine
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference29 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;1:1.
2. Al-Shamsi HO, Al Farsi A, Ellis PM. Stage III non-small-cell lung cancer: establishing a benchmark for the proportion of patients suitable for radical treatment. Clin Lung Cancer. 2014;15(4):274–80.
3. Kazandjian D, Blumenthal GM, Chen HY, He K, Patel M, Justice R, et al. FDA approval summary: crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangements. Oncologist. 2014;19(10):e5-11.
4. Mohtar N, Parumasivam T, Gazzali AM, Tan CS, Tan ML, Othman R, et al. Advanced nanoparticle-based drug delivery systems and their cellular evaluation for non-small cell lung cancer treatment. Cancers (Basel). 2021;13(14):1.
5. He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657–66.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献